Adverse events34

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 34

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Malaise	General disorders	Relugolix 40 mg	8	138
other	Malaise	General disorders	Leuprorelin 1.88 mg or 3.75 mg	5	142
other	Viral upper respiratory tract infection	Infections and infestations	Relugolix 40 mg	39	138
other	Viral upper respiratory tract infection	Infections and infestations	Leuprorelin 1.88 mg or 3.75 mg	46	142
other	Gamma-glutamyltransferase increased	Investigations	Relugolix 40 mg	7	138
other	Gamma-glutamyltransferase increased	Investigations	Leuprorelin 1.88 mg or 3.75 mg	9	142
other	Bone density decreased	Investigations	Relugolix 40 mg	6	138
other	Bone density decreased	Investigations	Leuprorelin 1.88 mg or 3.75 mg	8	142
other	Bone resorption test abnormal	Investigations	Relugolix 40 mg	7	138
other	Bone resorption test abnormal	Investigations	Leuprorelin 1.88 mg or 3.75 mg	7	142
other	Arthralgia	Musculoskeletal and connective tissue disorders	Relugolix 40 mg	8	138
other	Arthralgia	Musculoskeletal and connective tissue disorders	Leuprorelin 1.88 mg or 3.75 mg	9	142
other	Resorption bone increased	Musculoskeletal and connective tissue disorders	Relugolix 40 mg	7	138
other	Resorption bone increased	Musculoskeletal and connective tissue disorders	Leuprorelin 1.88 mg or 3.75 mg	8	142
other	Headache	Nervous system disorders	Relugolix 40 mg	21	138
other	Headache	Nervous system disorders	Leuprorelin 1.88 mg or 3.75 mg	14	142
other	Dizziness	Nervous system disorders	Relugolix 40 mg	9	138
other	Dizziness	Nervous system disorders	Leuprorelin 1.88 mg or 3.75 mg	7	142
other	Somnolence	Nervous system disorders	Relugolix 40 mg	7	138
other	Somnolence	Nervous system disorders	Leuprorelin 1.88 mg or 3.75 mg	6	142

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02655237/events

API reference For AI assistants

Adverse events34

Sources 3

Read this list from software.